Abstract |
Galectin-3, a microglia/macrophage-derived inflammatory mediator, plays a role in the stroke progression. In this single-center prospective study, we included 288 consecutive patients with a first-ever acute ischemic stroke to assess the association between galectin-3 serum level and clinical severity at admission and outcome at discharge by univariate and multivariate logistic regression. The results were presented as odds ratios (OR) and 95% confidence intervals (CI). Patients with high severity and poor outcomes had higher serum levels of galectin-3 (P<0.001 and P<0.001). Multivariate analysis suggested that a galectin-3 serum level in the highest quartile (The lowest three quartiles[Q1-3] as the reference) was associated with poor functional outcome (OR, 3.15; 95% CI, 2.44-3.87). The AUC (standard error) for the NIHSS and the combined model were 0.764 (0.031) and 0.823 (0.027), corresponding to a difference of 0.059 (0.004). This study shows that higher serum levels of galectin-3 are associated with stroke severity at admission and stroke prognosis at discharge in ischemic stroke.
|
Authors | Jia-Jun Zhuang, Li Zhou, Yan-Hua Zheng, Yan-Sheng Ding |
Journal | Aging
(Aging (Albany NY))
Vol. 13
Issue 5
Pg. 7454-7464
(03 03 2021)
ISSN: 1945-4589 [Electronic] United States |
PMID | 33686023
(Publication Type: Journal Article)
|
Chemical References |
- Blood Proteins
- Galectins
- LGALS3 protein, human
|
Topics |
- Aged
- Blood Proteins
- Female
- Galectins
(blood)
- Humans
- Ischemic Stroke
(blood, diagnosis, pathology)
- Male
- Middle Aged
- Multivariate Analysis
- Prognosis
- Prospective Studies
- ROC Curve
- Severity of Illness Index
|